Plate Nº 14 · recorded November 17, 2026
Health & Medicine ResearchReported finding
Fully Drug-Resistant Fungus Found in Kenya May Not Be the Last
A Kenyan patient's infection resisted 13 antimicrobials, marking only the second fully drug-resistant C. auris case — and experts say detection gaps hide more.
By Nathan Brooks4 min read788 words
In brief
- A 28-year-old woman in Kenya had a C. auris infection that resisted at least 13 antimicrobial drugs.
- This is the second-ever documented pan-resistant C. auris case; the first was reported in 2022 in New Jersey.
- C. auris, first identified in Japan in 2009, has now been detected in more than 40 countries across six continents.
- Findings were published in Scientific Reports in 2025.
- Detection is limited: many labs worldwide cannot identify yeast species, and confirmation can take weeks.

A fungal infection that survived at least 13 different antimicrobial drugs has been identified in a 28-year-old woman in Kenya, and experts warn more cases are almost certainly going undetected. The strain of Candidozyma auris (C. auris) resisted every class of antifungal drug medicine currently has. The findings appeared in Scientific Reports last month.
The patient developed an infected wound after surgery. Doctors exhausted their options with no success, and the outcome of her case has not been made public. The report's authors described an "escalating threat of untreatable fungal infections" and stressed an "urgent need" for better detection and treatment of fungal disease.
This is only the second documented case of a fully resistant C. auris infection. The first was reported in 2022 in a 29-year-old woman from New Jersey, found after a multi-organ transplant. Researchers still don't know whether the two cases arose independently, or whether the Kenyan infection descended from the American one and was imported unnoticed.
Is this fungus new?
No. C. auris was first identified in 2009, in the ear of a Japanese patient. Since then it has turned up in more than 40 countries across six continents, and some strains have already evolved resistance to the most powerful antifungal drugs available.
Prof Matthew Fisher, professor of fungal disease epidemiology at Imperial College London, said the Kenyan case is unlikely to stand alone. "The real figure is almost certainly higher and we are seeing only what we have the capacity to look for," he said.
Who is at risk?
For now, the danger is largely inside hospitals. Dr Neil Stone, an infectious diseases consultant and professor of infection and immunity at University College London, said drug-resistant fungal infections are "mainly confined to hospital environments". They are "reason enough to worry", he added, but "unlikely to affect people going about their daily business". Fisher agreed: healthy people aren't at risk, but some hospitalised patients "very much are".
The reason is entry points. C. auris lives on the skin, and intact skin is a strong barrier. "The fungus can sit there for months doing no harm at all," said Fisher. In hospital, though, intravenous lines and urinary catheters can give the fungus a "direct road into the bloodstream or bladder".
Unlike black mould or mushrooms, C. auris is a yeast — a microscopic, single-celled fungus invisible to the naked eye. People can carry it for weeks or months without symptoms, depositing it on bedrails, door handles and medical equipment. Fisher said the yeast is "unusually good" at forming sticky biofilms on plastic, which shield it from immune cells and drugs. Broad-spectrum antibiotics can also wipe out bacteria that would normally keep fungi in check. That puts intensive care patients — often immunosuppressed and reliant on plastic devices — at particular risk. "If it becomes invasive – for example, when it is in the bloodstream – this is life-threatening and always needs treatment," said Stone.
Does resistance make it more contagious?
Not directly. "Drug resistance and transmissibility are largely independent traits," Fisher explained. But resistance buys time: the resistant strain survives treatment, colonises patients for longer, and gets more opportunities to transmit onward. Once established in a hospital, C. auris is "very hard work" to eradicate, Fisher added, because it survives for weeks on dry surfaces and tolerates some common disinfectants.
How do you fight a fungus no drug can kill?
Hygiene, for a start. Fisher noted that C. auris has previously been contained through screening contacts, isolating cases and using the right disinfectants. Dr Johanna Rhodes, an assistant professor at the University of Birmingham who researches antifungal resistance, said recommended hygiene methods "should work regardless of whether [the fungi] are resistant to one drug or four". But she cautioned this needs confirming: an organism that has evolved pan-resistance may carry other mutations that help it circumvent hygiene measures.
Doctors also have options beyond drugs, according to Stone. These include removing contaminated devices such as intravenous lines, surgically removing infected tissue, and trying combinations of antifungals that might work together.
What's the real bottleneck?
Detection. "C. auris is routinely misidentified by older biochemical identification systems, and a great many laboratories worldwide cannot identify yeasts to species at all," said Fisher. Even symptomatic infection often looks generic — typically a fever that won't respond to antibiotics — and confirming it requires a lab test that not every hospital can run, with results sometimes taking weeks.
Fisher warned that the quiet spread matters more than any headline outbreak: "My concern is less an explosive outbreak than quiet endemicity. For every invasive infection there are several silently colonised patients – so you only see the outbreak if you go looking for it."
via sciencefocus.com (Source)
More from Nathan Brooks
Show full bio
Market editor covering companies, deals and strategy in general science news at SciBeat.
456 articles
Nearby plates
- Candida auris thickens its wall during antifungal treatment
- Sewers could detect deadly fungal infections before hospitals do
- Scientists Find a Way to Kill a Drug-Resistant Deadly Fungus
- FDA-Cleared Urine Test Detects Deadly Mold Infection Within Hours
- Farm Fungicides Keep Aspergillus Drug Resistance Alive, Study Finds